Posted by Michael Wonder on 04 Feb 2024
Ruxolitinib phosphate for the treatment of patients with non-segmental vitiligo
31 January 2024 - The Department of Health and Social Care has asked NICE to produce guidance on using ruxolitinib in the NHS in England.
For the time being, ruxolitinib phosphate is not recommended for the treatment of patients 12 years of age and older with non-segmental vitiligo with facial involvement.
